Engineered Bacteria for Augmented In Situ Tumor Vaccination

The authors illustrate the mechanisms of bacteria as both efficient tumor immunogenic cell death inducers, and tumor-targeted delivery platforms. They then review the engineering strategies for designing bacteria-based in situ vaccination, including chemical modification, nanotechnology, and genetic engineering.